Zoonotic & Vector-Borne Diseases

>

Latest News

Lassa Fever Vaccine Study Enrollment Begins
Lassa Fever Vaccine Study Enrollment Begins

March 17th 2025

The vaccine is based on an attenuated rabies vaccine that was subsequently inactivated to make the vaccine candidate. The National Institutes of Health (NIH) is sponsoring the trial.

FDA Pauses BioNTech’s Malaria Vaccine Trial Amid Broader Vaccine Challenges
FDA Pauses BioNTech’s Malaria Vaccine Trial Amid Broader Vaccine Challenges

March 5th 2025

Top FDA Approvals and Updates from February 2025 in Infectious Disease
Top FDA Approvals and Updates from February 2025 in Infectious Disease

March 3rd 2025

FDA Approves Bavarian Nordic’s Chikungunya Vaccine or Those 12 and Older
FDA Approves Bavarian Nordic’s Chikungunya Vaccine or Those 12 and Older

February 14th 2025

Insects May Aid Spread of Fluconazole-Resistant Candida auris
Insects May Aid Spread of Fluconazole-Resistant Candida auris

February 13th 2025

Video Series
Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.